Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers-Based Model.

Journal: Cancer medicine
PMID:

Abstract

BACKGROUND: Morphological and vascular characteristics of breast cancer can change during neoadjuvant chemotherapy (NAC). Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)-acquired pre- and mid-treatment quantitatively capture information about tumor heterogeneity as potential earlier indicators of pathological complete response (pCR) to NAC in breast cancer.

Authors

  • Maria Colomba Comes
    Laboratorio di Biostatistica e Bioinformatica, Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Annarita Fanizzi
    Laboratorio di Biostatistica e Bioinformatica, Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Samantha Bove
    Laboratorio di Biostatistica e Bioinformatica, Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Luca Boldrini
    Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Agnese Latorre
  • Deniz Can Guven
    Department of Medical Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.
  • Serena Iacovelli
    Trial Office, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II" Bari, Bari, Italy.
  • Tiziana Talienti
    Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II"Bari, Bari, Italy.
  • Alessandro Rizzo
    Department of Electronics and Telecommunications, Politecnico di Torino, Torino, Italy. alessandro.rizzo@polito.it.
  • Francesco Alfredo Zito
    Unità Operativa Complessi di Anatomia Patologia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Raffaella Massafra
    Laboratorio di Biostatistica e Bioinformatica, Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.